Evidence map›Paper›PMID 41971470›Full record

ArticleCase reports in obstetrics and gynecology2026

A Rare Massive Seromucinous Cystadenoma of the Ovary in a 26-Year-Old Female Persisting for 9 Years: A Case Report.

Marah Kakeh, Mohammad Alhalabi, Wael Wazan, Rasha Abbassi, Abeer Kanjawi, Haitham Abbassi

Abstract read
In one paragraph

Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marah KakehDepartment of Obstetrics and Gynecology, University of Damascus Faculty of Medicine, Damascus, Damascus Governorate, Syria, damascusuniversity.edu.sy.ORCID https://orcid.org/0009-0006-2378-2991
Mohammad AlhalabiDepartment of Internal Medicine, University of Damascus Faculty of Medicine, Damascus, Damascus Governorate, Syria, damascusuniversity.edu.sy.ORCID https://orcid.org/0000-0002-7641-1186
Wael WazanDepartment of Obstetrics and Gynecology, University of Damascus Faculty of Medicine, Damascus, Damascus Governorate, Syria, damascusuniversity.edu.sy.
Rasha AbbassiDepartment of Obstetrics and Gynecology, University of Damascus Faculty of Medicine, Damascus, Damascus Governorate, Syria, damascusuniversity.edu.sy.
Abeer KanjawiDepartment of Histopathology, University of Damascus Faculty of Medicine, Damascus, Damascus Governorate, Syria, damascusuniversity.edu.sy.
Haitham AbbassiDepartment of Obstetrics and Gynecology, University of Damascus Faculty of Medicine, Damascus, Damascus Governorate, Syria, damascusuniversity.edu.sy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant ovarian tumors (GOTs) are uncommon ovary neoplasms with no universally accepted definition. They are typically noncancerous, with a mucinous subtype being the most common characteristic. Epithelial ovarian tumors are classified by cell type into serous, endometrioid, clear cell, mucinous, seromucinous, or transitional. Seromucinous cystadenomas are largely asymptomatic and can present with massive dimensions in late diagnoses, especially in low-to-middle-income regions. In this case, a 26-year-old nulliparous Arab woman presented with a giant ovarian cyst in her reproductive age, undiagnosed for 9 years, which turned out to be a benign histopathology of seromucinous cystadenoma. The clinical presentation was nonspecific, as large ovarian cysts are often asymptomatic until they reach a substantial size to affect the quality of life and fertility. She had progressive abdominal swelling first noticed 6 years ago, but she started developing a feeling of fullness, constipation, nausea, vomiting, and urinary hesitancy with painful micturition 5 months prior to presentation with marked distress. The cystadenoma was excised without complications, through the exploratory laparotomy, and a left salpingo-oophorectomy with right cystectomy was performed. Seromucinous cystadenomas were first classified in 2014 by the World Health Organization (WHO) as a new entity and a rare subtype of ovarian epithelial tumors. Patients with benign seromucinous cystadenomas have an excellent prognosis, especially with complete surgical removal. Raising awareness and increasing access to gynecological care in low- and middle-income countries are essential for the long-term well-being and health of patients with giant ovarian cysts.

Indexed as

benign ovarian tumorscase reportgiant ovarian cystovarian neoplasmseromucinous cystadenoma

Identifiers

PMID41971470
PMCPMC13066506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.